Our team

Claudio Albrecht, Founder

Claudio Albrecht, co-founder and managing partner of Albrecht, Prock & Partners was until August 31st, 2018 CEO of the publicly listed STADA AG. Before this assignment Claudio worked in and with the Generic industry for more than 30 years.
Claudio started his pharmaceutical career at Sandoz in 1987 in Austria and became General Manager of its generic businesses in the Netherlands, in Germany and the USA, before leaving to become CEO of the Ratiopharm Group in 2000. In his time as CEO of the Ratiopharm Group he was driving the internationalization process  of the German drug maker beyond Europe and was material for the initiation of the development, manufacturing and commercialization project  of Ratiopharm’s Biosimilars program.  Ratiopharm was first to market with the Biosimilar Filgrastim in Europe.
In 2007 Claudio founded together with Peter Prock the strategy consulting firm CoMeth in Slovakia before he was asked to assume the role of CEO and Chairman of the Board of the Actavis Group. Actavis was operating in over 50 countries worldwide with standalone 2012 revenues in excess of € 2billion. Under his leadership, Actavis was sold to Watson for 6 bio US$, which represented an above average industry multiple. As CEO of Actavis Claudio initiated a total turn around process and started a joint venture for the development and commercialization of recombinant Insulin and its Analogues with the objective to build the first Generic “one stop shop” in Diabetes.
After the divestiture of Actavis,  Claudio founded with Peter Prock the Zug/Switzerland based Albrecht, Prock & Partners AG. Together with Private Equity and strategic investors AP&P worked on numerous acquisition projects amongst which the take private initiative for STADA AG was the most significant. STADA AG was the largest leveraged buyout of a German listed company ever. Claudio agreed to manage the company for an interim period of one year and led all the necessary changes and strategic initiatives. In September 2018 Claudio returned to AP&P. Claudio holds a PhD in law.

Peter Prock, Founder

Peter Prock, co-founder and managing partner of Albrecht, Prock & Partners was, until 2012 the Deputy CEO of the Actavis Group and as such a decisive player in the turn around and divestiture of the company. Peter started his pharmaceutical career at Sandoz and worked in several positions in Austria, Spain, USA and Germany before leaving to become the CFO of the Ratiopharm Group , before its acquisition by Teva. After the divestiture of Actavis Peter founded together with Claudio AP&P and took on many project assignments in the Generic industry amongst others he also acted for 2 years as interim-CEO for Polpharma and serves on the board of several Pharmaceutical companies. Peter holds a Masters degree in Business Administration.

Wolter Kuizinga, Senior Partner

Wolter Kuizinga, partner of Albrecht, Prock & Partners, served as member of the Board of the Actavis Group in the capacity of Executive Vice-President Business Development. Wolter started his career in Solvay in 1987, being responsible for contracting out sterile manufacturing. After four years he joined Ciba-Geigy to define and build Ciba’s European generics portfolio. After the merger with Sandoz, Wolter co-founded Disphar International, a leading European generics development and out-licensing company, where he was responsible for the company’s Portfolio Management, Business Development and Legal Affairs. Wolter holds a Pharmacist’s degree from the University of Utrecht (NL) and an MBA from the University of Bradford (UK).

Jeff Rope, Senior Partner

Jeff Rope served as Global Head of Technical Operations for Sandoz and a member of the Sandoz Executive Committee. Jeff was responsible for a network of more than 30 manufacturing sites and external supply organisations supplying more than 160 countries worldwide. Jeff has over 35 years experience in Pharmaceutical Operations. Previously Jeff was Executive VP Global Operations for Actavis and has held Plant leadership roles in Pfizer Global Manufacturing. Jeff has a NZCS in Chemistry from Auckland Technical University, a Diploma in Analytical Chemistry from the Royal Society of Chemistry, an Executive MBA from University College Cork and is currently undertaking an MSC in Personal and Organisational coaching at UCC.

Sean Bowler,  Partner

Sean Bowler, partner of Albrecht, Prock & Partners, is an engineer who has been Head of Global Engineering and HSE in  two major pharmaceutical companies. Sean started his career in API  manufacturing, and  worked in a number of positions of increasing responsibility in the industry. With extensive global operational, engineering and HSE experience. He has successfully developed and managed corporate systems in areas such as capital management, project and program  delivery, asset life cycle management, network optimisation,  people development in technical roles and safety performance. Sean has a track record in delivering projects globally,  and has  successfully managed project portfolios of up to $750M in value. Sean is a Chemical Engineer, with an MBA. He is currently completing a research doctorate with Cranfield University, UK, on the determinants of performance  in global production networks.

Nadeem Aziz,  Partner

Nadeem Aziz is a partner at Albrecht Prock & Partners and was formerly the Head of Strategic Financial Planning and Analysis for Actavis Group where he was involved in supporting a number of M&A initiatives and business transformational projects. He also served as the Group Internal Audit Director for Actavis and supported the Board with analysis of risk, control and performance issues across the organisation.
Nadeem also held senior commercial business planning roles within a number of major multinational organisations. This has allowed him to gain best practice insights across a wide range of industry sectors. He has served as the Director for Global Business Analysis at American Express and later taking on a more regional role as the Director for European Sales Planning and Pricing. He also served as Director for European Financial Planning and Analysis at Electronic Arts, as well as holding a number of senior management roles within Sony, Emirate Airlines and Seagram. Nadeem is also currently a Board Director of a major NHS Foundation Hospital Trust in the UK. Nadeem is a qualified Chartered Management Accountant (ACMA) with an MBA from Sheffield Business School in the UK. He also holds a number of other UK postgraduate qualifications in Management Studies (DMS), Marketing (DipM), Auditing and is currently a Fellow of the British Chartered Institute of Management (FCMI) and a Certified Business Coach.


Peter Lovegren, founder and owner of Legaris - associated with APP

Peter Løvgren graduated in law from Aarhus University in 1998. Peter was trained as a lawyer at Bech-Brun & Trolle Law Firm (now Bech-Bruun) in Copenhagen where he worked in the law firm’s IP Department and the Corporate/M&A Department. In 2000/2001 Peter was seconded from the law firm to the corporate legal department of the industrial conglomerate FLS Industries A/S.
From 2004 to 2011 Peter worked as Head of Legal Department in the pharmaceutical company Actavis Group where he was responsible for corporate legal affairs in Western Europe, Middle East and Africa.
Peter is an experienced teacher, and in his capacity as external lecturer he has taught a number of legal courses at Copenhagen University and Copenhagen Business School (CBS).
In November 2011 Peter founded Legaris Law Firm.
We are working with Peter since many years and have collaborated on a series of projects where Peter was taking care of all legal aspects of the joint projects


Markus Unger, Partner

Markus is a partner at Albrecht Prock & Partners and was formerly VP for Comp &/ Ben for Actavis Group where Markus was instrumental in designing, implementing and controlling various Compensation and Benefits projects and initiatives. He was also responsible for the global HR budget, developing and introducing of various HR strategies, pooling of insurances and leading DD teams in various COC situations.

Prior to his engagement with Actavis, Markus served as CFO for various Healthcare companies and Fast moving Consumer goods companies.

Markus is a certified public accountant and graduated as an MBA from GSBA Zuerich / SUNY New York.


Petar Bast, Partner

Petar Bast, Partner at Albrecht, Prock & Partners, until recently served as Vice-President Business Intelligence at Allergan (previously Actavis). After Allergan Petar founded a Swiss consulting and pharma company with a group of ex-Actavis colleagues.

Petar started his career in Copenhagen in 1995, developing manufacturing plants for Ferring and Lundbeck. Later he worked for Amgen in various commercial/ marketing roles in the UK and Switzerland. Before joining Actavis, Petar built up the Business Analysis function at Vifor Pharma. Petar holds an MBA from London Business School, an M.Sc. (Pharm.Med.) from Essen University, a B.Com. (Org. Development) from Copenhagen Business School and an M.Sc. (Pharm. Eng.) from the Technical university of Denmark